Leah Tate - 13 May 2025 Form 4 Insider Report for BELDEN INC. (BDC)

Reporting relationship: SVP - HR
Issuer ticker: BDC
Reported as of: 13 May 2025
Net transaction value: -$46,761
SEC form: 4
Accepted by SEC: 14 May 2025, 17:41:49 UTC
Prior SEC filing: 28 Feb 2025
Next SEC filing: 11 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Brian E. Anderson, attorney-in-fact for Leah Tate

Key filing fact

Leah Tate filed Form 4 for BELDEN INC. (BDC) on 14 May 2025.

Key facts

This page summarizes Leah Tate's Form 4 filing for BELDEN INC. (BDC).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 May 2025, 17:41.

Change

Previous filing in this sequence was filed on 28 Feb 2025.
Current net transaction value: -$46,761.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001916589 Primary reporting owner

Tate Leah

Relationship: SVP - HR
Address: C/O BELDEN INC., 1 N. BRENTWOOD BLVD., 15TH FLOOR, ST. LOUIS
Signature: /s/ Brian E. Anderson, attorney-in-fact for Leah Tate
Signature date: 14 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BDC transaction

Common Stock

Options Exercise

Transaction value: $142,979
Shares: +1,667
Change %: +5.5%
Price: $85.77
Shares after: 31,837
Date: 13 May 2025
Ownership: Direct
Footnotes: F1

BDC transaction

Common Stock

Disposed to Issuer

Transaction value: $163,489
Shares: -1,436
Change %: -4.5%
Price: $113.85
Shares after: 30,401
Date: 13 May 2025
Ownership: Direct
Footnotes: F2

BDC transaction

Common Stock

Sale

Transaction value: $26,251
Shares: -231
Change %: -0.76%
Price: $113.64
Shares after: 30,170
Date: 14 May 2025
Ownership: Direct
Footnotes: F4

BDC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,360
Date: 13 May 2025
Ownership: By Spouse

BDC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,164
Date: 13 May 2025
Ownership: By 401(k) Plan
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BDC transaction Derivative

Stock Appreciation Rights

Options Exercise

Transaction value: $0
Shares: -1,667
Change %: -50%
Price: $0.000000
Shares after: 1,666
Date: 13 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,667
Exercise price: $85.77
Footnotes: F1, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Tate on November 8, 2024.

Footnote F2

This represents the difference between the number of SARs exercised (1,667) and the number of shares issued as a result of the exercise (231). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($113.85) and the exercise price ($85.77). Additional shares were then withheld to satisfy the Company's tax withholding obligations.

Footnote F3

Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.

Footnote F4

The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Tate on November 8, 2024.

Footnote F5

The original grant of stock appreciation rights became exercisable in equal portions on the first three anniversaries of the grant date.